Ceribell (CBLL) Change in Inventory (2023 - 2026)
Ceribell (CBLL) posted Change in Inventory of -$386000.0 for Q1 2026, down 130.54% on a QoQ basis from $1.3 million in Q4 2025, and down 0.78% year-over-year from -$389047.4 in Q1 2025.
Ceribell (CBLL) Change in Inventory (2023 - 2026) Analysis & Trends
Ceribell's Change in Inventory history runs 4 years deep, the most recent figure standing at -$386000.0 for Q1 2026.
- Quarterly Change in Inventory fell 0.78% year-over-year to -$386000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $348000.0 (up 1.16% YoY) and the FY2025 annual result came in at $351000.0, down 67.13% from the prior year.
- Change in Inventory was -$386000.0 for Q1 2026 at Ceribell, down from $1.3 million in the prior quarter.
- Across five years, Change in Inventory topped out at $1.3 million in Q4 2025 and bottomed at -$554000.0 in Q2 2025.
- A 4-year average of $75100.0 and a median of -$129000.0 in 2023 frame the typical range for Change in Inventory.
- Peak annual rise in Change in Inventory reached 4581.48% in 2025, while the deepest fall reached 212.32% in 2025.
- Ceribell's Change in Inventory stood at -$282000.0 in 2023, then soared by 109.57% to $27000.0 in 2024, then surged by 4581.48% to $1.3 million in 2025, then slumped by 130.54% to -$386000.0 in 2026.
- Business Quant data shows CBLL's Change in Inventory at -$386000.0 in Q1 2026, $1.3 million in Q4 2025, and $24000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 420.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 127.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 65.20 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -264.59 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 171.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | -386,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -386,000.00 |
| Mar 31, 2026 | -386,000.00 |
| Dec 31, 2025 | 1.26 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 24,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | -554,000.00 |
| Jun 30, 2025 | -554,000.00 |
| Mar 31, 2025 | -383,000.00 |
| Mar 31, 2025 | -383,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 1.15 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | -452,000.00 |
| Jun 30, 2024 | -452,000.00 |
| Mar 31, 2024 | 341,000.00 |
| Mar 31, 2024 | 341,000.00 |
| Dec 31, 2023 | -282,000.00 |
| Dec 31, 2023 | -282,000.00 |